V5med Lung AI is an FDA-cleared AI-powered computer-aided detection (CADe) system developed by V5med. It is specifically designed to support global low-dose CT (LDCT) lung cancer screening workflows, assisting radiologists in the rapid and accurate detection and evaluation of pulmonary nodules.

Features and Advantages

• Identify and label the lung nodules by 3D nodule reconstruction technology.
• Be able to detect the nodule size from 4mm to 30mm up to 95% sensitivity.
• Accelerate the physicians’ interpretation and reporting procedure.
• Precisely detect the small size (4mm–6mm) nodule and GGO type with high sensitivity.
• Increase the physicians’ nodule detection accuracy up to 20%.
• Enhance the physicians’ cancer nodule detection accuracy by 11%.
• Automatically make the nodule growth comparison among different scan times.
• Provide ACR Lung-RADS and Fleischner Society Guideline.
• Generate the comprehensive report immediately and connect to PACS and HIS.
• Facilitates concurrent use by multiple users and modalities.